Do physicians have a conflict of interest when they accept financial incentives from pharmaceutical giants? This debate has simmered for years, prompting discussions among medical communities and policymakers. Unpacking this complex issue requires examining the implications of such relationships for patient care, medical decision-making, and the integrity of the healthcare profession.